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Abstract
A special- care neonatal unit from a large public hospital in Malawi was noted as having more frequent, difficult- to- treat infec-
tions, and a suspected outbreak of multi- drug- resistant Klebsiella pneumoniae was investigated using genomic characterisa-
tion. All K. pneumoniae bloodstream infections (BSIs) from patients in the neonatal ward (n=62), and a subset of K. pneumoniae 
BSI isolates (n=38) from other paediatric wards in the hospital, collected over a 4 year period were studied. After whole genome 
sequencing, the strain sequence types (STs), plasmid types, virulence and resistance genes were identified. One ST340 clone, 
part of clonal complex 258 (CC258) and an ST that drives hospital outbreaks worldwide, harbouring numerous resistance genes 
and plasmids, was implicated as the likely cause of the outbreak. This study contributes molecular information necessary for 
tracking and characterizing this important hospital pathogen in sub- Saharan Africa.
DATA SUMMARY
The Klebsiella pneumoniae genome sequences completed 
using an Illumina platform from this study are deposited 
in GenBank under project no. PRJNA641987 (https://www. 
ncbi. nlm. nih. gov/ bioproject/? term= PRJNA641987) and the 
European Nucleotide Archive under project no. PRJEB19322 
(https://www. ebi. ac. uk/ ena/ browser/ view/ PRJEB19322). 
The previously published K. pneumoniae sequences used as 
benchmarks of global context can be found in the European 
Nucleotide Archive under accession no. ERP000165.
Klebsiella pneumoniae is an opportunistic pathogen respon-
sible for an increasing burden of hospital- acquired infec-
tions globally. It readily acquires antimicrobial resistance 
determinants via mobile genetic elements and plasmids [1], 
with particular sequence types (STs), such as those from 
clonal complex (CC) 258 (ST258, ST11), ST14/15 and ST405 
reported to cause a large proportion of cephalosporin- and 
carbapenem- resistant infections with high mortality [2]. 
Critically, sepsis caused by multi- drug- resistant (MDR) K. 
pneumoniae is a growing challenge in neonatal care units; 
one systematic review of extended spectrum beta- lactamase 
(ESBL)- producing Enterobacteriaceae in neonatal care units 
reported that ESBL K. pneumoniae is the pathogen most 
frequently responsible for outbreaks in these settings, and is 
associated with a mortality rate of 31 % [3]. There are multiple 
reports detailing the prevalence and genetic epidemiology 
of MDR K. pneumoniae causing hospital outbreaks in high- 
income settings [2, 4, 5]. However, reports from low- and 
middle- income settings, where such data are of immense 
value in implementing appropriate infection prevention 
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Queen Elizabeth Central Hospital (QECH) is the referral 
hospital in southern Malawi and care is free at the point of 
delivery. QECH serves both as district hospital for Blantyre 
(population 900 000) and is the tertiary referral hospital for 
the surrounding districts. QECH admits approximately 10 000 
adult (aged ≥16 years) and 30 000 paediatric (aged <16 years) 
medical patients annually. Chatinkha is a 70- bed neonatal 
special care unit in QECH. Given that Chatinkha predomi-
nantly admits neonates born at QECH with complications, 
the majority of blood stream infections (BSIs) diagnosed on 
this unit are considered to be hospital- acquired. At QECH, 
all children with clinically suspected sepsis undergo a blood 
culture (BC) test as previously described [6]. The BC service 
typically identifies  fewer than two K. pneumoniae BSI on 
Chatinkha each month, but a spike in K. pneumoniae isolates 
was observed in February (n=7) and March (n=9) 2014. 
The number of cases temporarily decreased, yet September 
to November 2014 showed a second peak in cases (Fig. 1). 
Despite Chatinkha having the smallest capacity of all of the 
paediatric wards at QECH, from February to November 2014 
over 75 % of all paediatric K. pneumoniae BSI (n=33/43) were 
from neonates admitted to Chatinkha. This rise was not due 
to an increase in the number of blood cultures taken, which 
remained stable (Fig. 2). Furthermore, K. pneumoniae BSIs in 
Chatinkha during this period were untreatable with locally 
available antibiotics (most commonly penicillin, gentamicin, 
cotrimoxazole; less commonly ciprofloxacin, ceftriaxone; 
carbapenems unavailable); most displayed identical anti-
microbial resistance patterns, suggesting the possibility of a 
clonal outbreak.
Here, we performed a genomic investigation into the 
suspected K. pneumoniae outbreak, sequencing genomes 
from February to November 2014 (boxed in Fig. 1) and all 
viable, archived K. pneumoniae BSI isolates from Chatinkha 
(n=62) and a subset of K. pneumoniae BSI isolates (n=38) 
from other paediatric wards, isolated from January 2012 to 
December 2015. Patient records were retrospectively analysed 
to establish mortality outcomes. Blood culture collection, 
processing and antimicrobial susceptibility testing methods, 
based on the disc diffusion method and BSAC guidelines, for 
isolates at QECH have been previously described [6].
All DNA samples (n=100) were extacted with a Wizard 
Genomic DNA Purification Kit (Promega) and subjected to 
whole genome sequencing using the Illumina HiSeq X- Ten 
platform at the Wellcome Sanger Centre, UK, and the Oxford 
Genomics Centre. Fourteen sequenced genomes failed initial 
quality control using Kraken (more than 5 % of a species not 
part of the K. pneumoniae species complex assigned) [7]; the 
remaining 86 samples (Chatinkha n=56, other wards n=30) 
yielded, on average, 2.3 million reads per sample and an 
average of 77 contigs (range 22–259). The sequences were 
deposited in the European Nucleotide Archive (ENA) under 
project number PRJNA641987 and NCBI under project 
number PRJEB19322.
Multilocus sequence (MLST) typing was performed in silico 
as described elsewhere [8]. Resistance genes were identified 
using SRST2 v0.2.0[9] (https:// github. com/ katholt/ srst2), 
plasmids using in silico PCR- based replicon typing [10] and 
PlasmidFinder version 2.0.1[11], capsular and O- antigen 
types using Kaptive (version 0.5.1; https:// github. com/ 
Impact Statement
Multi- drug- resistant Klebsiella pneumoniae is an impor-
tant nosocomial pathogen that has been flagged by the 
World Health Organization and the Centre for Disease 
Control as an urgent threat to human health. Despite the 
importance of this pathogen and its worldwide distribu-
tion, the reporting and tracking of K. pneumoniae across 
sub- Saharan Africa is limited, and even less so from 
Malawi, especially using genomic data. In this study, we 
investigate an outbreak of extremely multiply resistant K. 
pneumoniae from a neonatal ward in a large public hospital 
in southern Malawi, using whole genome sequencing, 
across a 4 year period (2012–2015). We analysed the 
genomes of the isolates using various approaches to 
understand the phylogenetic typing features, antibiotic 
resistance and virulence properties and compared these 
with sequenced strains from other paedeatric wards in 
the hospital and put them in a global context. This study 
helps to understand the optimal local treatment options 
available and establish the virulent strain types of this 
important pathogen that are circulating in Malawi as well 
as adding information to the critical global network of K. 
pneumoniae genomic data.
Fig. 1. Schematic showing the location, sequence type (ST) and date 
of isolation of the K. pneumoniae isolates that were subjected to 
whole genome sequencing (n=86). STs that were identified more than 
once in the dataset are highlighted with a coloured box reflecting the 
STs. Singleton STs are not highlighted. Non- viable isolates (n=4) and 
those that failed sequencing (n=14) but were earlier confirmed as K. 
pneumoniae by the diagnostic laboratory are marked on the schematic 
as ‘XXX’ in order to give a complete picture of the number of BSI K. 
pneumoniae cases reported from Chatinkha each month during the 
study period. Months where no cases were reported are omitted from 
the schematic. The suspected outbreak period is highlighted with a 
black outline.
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katholt/ Kaptive) [12] and virulence genes using Kleborate 
v0.3.0 (https:// github. com/ katholt/ Kleborate) [13, 14]. In 
order to place the study dataset within a global context, we 
compared our genomes to a previously published dataset 
from an international K. pneumoniae study [2]. A core gene 
alignment of the combined genomic dataset was generated 
using roary [15] and, from this, single nucleotide variants 
were used to generate a phylogeny with RaxML v.7.8.6 [16].
Whole genome sequencing analysis identified two lineages, 
ST340 and ST14, as the dominant K. pneumoniae STs recov-
ered from neonates admitted to Chatinkha (Fig. 1).
THERE WAS A DISCRETE OUTBREAK OF MDR 
ST340
ST340, an ST within CC258 that has been associated with 
MDR hospital infections worldwide [17, 18], accounted for 
almost a third (30%, n=17/56) of all K. pneumoniae isolated 
from Chatinkha during the study period. All ST340 isolates 
were capsular type 15 and serotype O4 and differed from one 
another by ≤30 SNPs (Fig. 3), indicating that a single ST340 
lineage was circulating in the ward over the entire study 
period. Over the suspected outbreak period, ST340 accounted 
for more than half of the K. pneumoniae BSIs from Chatinkha 
(58%, n=14/24), strongly suggesting that dissemination of 
this clonal strain within Chatinkha was responsible for the 
peak in BSIs observed from February to November 2014. The 
ST340 isolates were resistant to augmentin, ampicillin, ceftri-
axone, chloramphenicol, ciprofloxacin, cotrimoxazole and 
gentamicin and susceptible only to amikacin, an antibiotic 
not locally available. Consistent with this, all ST340 isolates 
harboured multiple antibiotic resistance genes, conserved 
between all ST340 isolates, namely blaCTX- M- 15, blaOXA- 1, blaOXA- 
2, blaOXA- 16, blaSHV- 11, blaTEM- 1 (beta- lactams), aac(6')- Ib- cr 
(quinolone), strAB (streptomycin), sul1 (sulphonamides), 
catA1, catA2 (phenicols), tetA(D) (tetracycline), aadA1, 
aadA2, aac(3’)- IIa (aminoglycosides), dfrA1, dfrA2 (trimeth-
oprim) and mph (macrolides), and a number of plasmids, 
including IncR and IncF types (see Fig. 4). Of the ST340 BSI 
cases reported in neonates on Chatinkha, outcome data were 
available for 13, four of whom died, bringing the case fatality 
rate to 31%, which is equivalent to other reports of MDR K. 
pneumoniae [2].
Prior to the outbreak, ST340 BSIs had only been isolated from 
Chatinkha on two previous occasions (May and November 
2013) (Fig. 1). These isolates differed from the first two ST340 
cases reported in February 2014 by  fewer than five SNPs 
(Fig. 3), confirming that closely related strains were circu-
lating in Chatinkha at least 6 months prior to the outbreak. 
Previous to this, ST340 was isolated on a single occasion 
from two other paedeatric wards, the earliest in February 
2013. These two ST340s isolates differed from the presumed 
outbreak ST340 precursor isolate by fewer than seven SNPs. 
Whilst we cannot confirm the exact date at which ST340 was 
seeded into QECH, this indicates that ST340 was circulating 
in the hospital at least a year prior to the outbreak. Following 
the outbreak, ST340 was identified twice more on Chatinkha: 
Fig. 2. Bar chart showing the number of K. pneumoniae- positive blood 
cultures for Chatinkha ward and other paediatric wards at QECH. The 
chart is overlaid with a scatter plot showing the total number of all 
blood cultures (including those positive for any bacteria and those 
that were culture- negative) taken from the paediatric wards at QECH, 
Malawi, from 2012 to 2015 divided by 100. Data on the total number of 
blood cultures taken were not available for 2012 and are not shown.
Fig. 3. Heatmap showing the number of SNP differences between 
the K. pneumoniae ST340 isolates sequenced as part of the outbreak 
investigation. To bring the relatedness of our samples into context 
with other ST340 isolates, the analysis includes a community- acquired 
Malawian ST340 sequenced as part of a previous study at QECH [6], 
a single ST340 isolate from a study in Kenya [20] and eight ST340 
genomes from the UK [21].
4
Cornick et al., Microbial Genomics 2021;7:000703
Fig. 4. The distribution of antimicrobial resistance elements within the K. pneumoniae isolates from QECH. The phylogeny is based 
on a core genome SNP alignment of the Malawian isolates (n=86), and the branches are labelled with the ST. The panel adjoining 
the phylogeny shows the antimicrobial resistance phenotype and the absence/presence of key antimicrobial resistance genes and 








. Quinolone resistance genes: aac3, aac6. Streptomycin 
resistance gene: strAB. Sulphonamide resistance gene: sul1. Chloramphenicol resistance genes: cat1, cat2. Tetracycline resistance gene: 
tetA. Aminoglycoside resistance genes: aadA, aad1. Trimethoprim resistance genes: dfrA1, dfrA2, dfrA14. Macrolide resistance gene: mph.
Fig. 5. Population structure of K. pneumoniae. A core genome phylogeny of the Malawian KP- I isolates (n=81) in the context of a 
previously published global dataset. Branch labels are annotated with ST. The inner coloured circle indicates if the Malawian isolates 
were recovered from the Chatinkha neonatal care unit, while the outer ring indicates the country of isolation.
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a single case in April 2015 and again a single case in October 
2015. October 2015 saw six cases of K. pneumoniae BSIs iden-
tified on Chatinkha, hinting at the start of another outbreak, 
but these six cases were caused by five different STs. The fact 
that ST340 continued to circulate in the ward after November 
2014 but did not to contribute to a further peak in cases 
suggests that the success of this clone during the outbreak 
period was not driven by genomic factors alone.
Interestingly, a recent study characterizing MDR Enterobac-
teriaceae, using PFGE and PCR, across northern and central 
Malawi, identified seven isolates of ST340 K. pneumoniae in 
2016–2017 [19]. This indicates that although MDR ST340 
strains appeared to be circulating across the whole country 
during this time period, these strains were probably not 
identifical clones of the outbreak in QECH because PCR 
confirmed that the nothern isolates carried different resist-
ance genes (eg blaKPC- 2).
ST14 DID NOT CONTRIBUTE TO THE 
OUTBREAK
Despite being the second most commonly isolated ST from 
Chatinkha (27%, n=15/56) during the study period, only a 
single ST14 case was reported during the outbreak period, 
in March 2014. ST14 showed a greater level of variation 
in their resistance profiles relative to ST340. These isolates 
were predominantly susceptible to locally available antibi-
otics (chloramphenicol and ciprofloxacin) in addition to 
amikacin and, thus, the ST14 infections would have been 
treatable (Fig. 4).
ST372 RELATED TO A PEAK IN CASES
ST372 (capsular type: 43, serotype: O2V1) also appeared to 
contribute to the peak in K. pneumoniae BSIs over the outbreak 
period as ST372 was responsible for 20.8 % (n=5/24) of cases. 
ST372 was first observed in February 2014 in Chatinkha and 
caused four BSI in 1 month and the remaining five K. pneu-
moniae BSIs reported during the outbreak period belonged to 
five different STs. ST372 isolates displayed relatively disparate 
resistance and plasmid profiles and may not be clonal (Fig. 4).
THE OUTBREAK STRAINS IN A GLOBAL 
CONTEXT
A core phylogeny was constructed to place isolates into a 
global context using a sequencing dataset of diverse K. pneu-
moniae isolates [2] (Fig. 5). Although no ST340 isolates were 
present in this dataset, the Malawian ST340 isolates were most 
closely related to ST258 isolates from the USA. Interestingly, 
ST14 strains from Malawi were clonally related (<100 SNPs) 
to international isolates with >99.9 % identity to isolates from 
Australia and the Netherlands, indicating a global spread. All 
ST372 isolates assayed in this study were from Malawi and we 
were unable to place them in a global context as no compara-
tive international strains were available in this dataset.
CONCLUSION
We studied K. pneumoniae BSIs isolated from neonates 
admitted to a neonatal unit over a 4 year period, encompassing 
a suspected outbreak in 2014, as well as a representative subset 
of K. pneumoniae BSI reported from other paediatric wards 
within the same hospital.
We show that ST340, and to a lesser extent ST372, caused 
an increase in BSIs reported on the neonatal ward in 2014. 
ST340 was observed in other wards prior to the outbreak, 
suggesting that it was circulating in the hospital prior to 
the outbreak. ST372 was not identified in other wards prior 
to the outbreak, but this may be due to the limitations of 
our sampling. In addition to the outbreak lineages, we 
observed a large cluster of ST14 isolates, which intermit-
tently contributed to no more than two BSI cases per month 
on Chatinkha. All other STs identified in Chatinkha over 
the sampling period were only observed in sporadic single 
isolate clusters. From the sequencing analysis alone, it is 
unclear what exact factors allowed the specific lineages to 
persist or successfully transmit within Chatinkha beyond 
antibiotic selection and this is under further investigation 
by performing genomics of environmental samples and staff 
swabs. Furthermore, continual monitoring of the hospital 
environment, especially for the re- emergence of MDR 
ST340, is urgently needed in order to implement measures 
to prevent the persistence and/or spread of these locally 
untreatable lineages.
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